Literature DB >> 430291

Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children.

J A Perman, S L Werlin, R J Grand, J B Watkins.   

Abstract

The accuracy of the serum ceruloplasmin level in distinguishing chronic active hepatitis from Wilson disease was compared to the 24-hour urinary copper excretion and hepatic copper content in 20 untreated patients with chronic active hepatitis and 25 with Wilson disease. Serum ceruloplasmin levels were decreased in five patients (25%) with chronic active hepatitis and were normal in seven patients (28%) with Wilson disease at the time of diagnosis. The 24-hour urinary copper excretion failed to provide accurate discrimination between the two groups, being elevated in all patients with Wilson disease and in five of eight patients with chronic active hepatitis studied. All patients with Wilson disease had hepatic copper levels greater than 400 microgram/gm dry weight, whereas patients with chronic active hepatitis had levels less than 300 microgram/gm dry weight. The discriminatory value of hepatic copper concentration makes this the most reliable test for differentiating chronic active hepatitis and Wilson disease in children and adolescents. The serum ceruloplasmin level may not be significantly accurate for definitive diagnosis in this age group.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430291     DOI: 10.1016/s0022-3476(79)80011-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Population screening and diagnostic strategies in screening family members of Wilson's disease patients.

Authors:  Huamei Li; Ran Tao; Lifang Liu; Shiqiang Shang
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

Review 3.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

4.  Biomarkers for diagnosis of Wilson's disease.

Authors:  Aidan Ryan; Sarah J Nevitt; Orla Tuohy; Paul Cook
Journal:  Cochrane Database Syst Rev       Date:  2019-11-19

5.  Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.

Authors:  Da-Wu Zeng; Yu-Rui Liu; Jie-Min Zhang; Yue-Yong Zhu; Su Lin; Jia You; You-Bing Li; Jing Chen; Qi Zheng; Jia-Ji Jiang; Jing Dong
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

6.  Comparative salivary proteome of hepatitis B- and C-infected patients.

Authors:  Lorena Da Rós Gonçalves; Isabele Batista Campanhon; Romênia R Domingues; Adriana F Paes Leme; Márcia Regina Soares da Silva
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

7.  The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.

Authors:  Rong Xu; Yong-Fang Jiang; Yong-Hong Zhang; Xu Yang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.